Committee Membership

advises the CEO and the Science Directors on the scientific and technical questions impacting the specification, design, commissioning and operation; experimental and user support facilities, and opportunities for scientific exploitation.

• Prof Richard Pattrick (Chair)
  University of Manchester (UK)
• Dr Andrew Thompson (Vice-Chair)
  SOLEIL (France)
• Dr Peter Ash
  Johnson Matthey (DISCo Representative)
• Dr John Barker
  Evotec (DISCo Representative)
• Dr Bridget Carragher
  New York Center for Structural Biology (USA)
• Dr Paul Fuoss
  Argonne National Laboratory (USA)
• Prof Gerhard Grübel
  DESY (Germany)
• Dr Tom Hase
  University of Warwick (UK) (Chair of the DUC)
• Dr Peter Hatton
  University of Durham (UK)
• Prof Tim Lodge
  University of Minnesota (USA)
• Prof Arwen Pearson
  The Hamburg Centre of Ultrafast Imaging (Germany)
• Dr Ilme Schlichting
  Max Planck Institute for Medical Research (Germany)
• Prof Christian Schroer
  DESY (Germany)
• Prof Moniek Tromp
  University of Amsterdam (Netherlands)

Membership as at April 2017

The Diamond User Committee has been set as a platform for discussion between Diamond and the user community of matters relating to the operation and strategy of Diamond.

• Dr Tom Hase (Chair)
  University of Warwick
• Dr Arnaud Basle
  University of Newcastle
• Dr Nick Brooks
  Imperial College London
• Dr Sam Chong
  University of Liverpool
• Dr Yvonne Grunder
  University of Liverpool
• Dr Tim Knowles
  University of Birmingham
• Dr Gareth Law
  University of Manchester
• Dr Ed Lowe
  University of Oxford
• Prof Colin Pulham
  University of Edinburgh
• Dr Laura Spagnolo
  University of Glasgow
• Dr Neil Telling
  Keele University
• Dr Amber Thompson
  University of Oxford
• Dr Andrew Thomas
  The University of Manchester

Membership as at April 2017

The Diamond Industrial Science Committee (DISCo) advises the CEO and Directors on opportunities for industry to be engaged in research at Diamond, industrial research priorities that will help shape operational strategy, including the best way to exploit the current suite of beamlines and to develop the case for investment in future beamlines, and to develop best practice for industrial engagement.

• Dr Malcolm Skingle (Chair)
  GlaxoSmithKline
• Dr Peter Ash
  Johnson Matthey
• Dr John Barker
  Evotec
• Dr Andrew Barrow
  Rolls-Royce
• Prof David Brown
  Argenta
• Dr Rob Cooke
  Heptares Therapeutics
• Dr Cheryl Doherty
  Pfizer
• Prof Peter Dowding
  Infineum
• Prof Jonathan Hyde
  NNL
• Prof Ken Lewtas
  Lewtas Science & Technologies
• Dr Jonathan Mitchener
  Innovate UK
• Dr Richard Storey
  AstraZeneca
• Dr Ian Tucker
  Unilever

Membership as at April 2017